amgen glp-1 drug Will 2 incretin drugs be better than 1 to for weight loss & to prevent weight regain? @Amgen thinks so, releases @Nature phase 1 study of AMG 133 (maridebart cafraglutide) a combination GLP-1 Medications for Weight Loss:

In this study, both the GLP-1MK-801-treated mice and the calorie-restricted mice exhibited improved insulin sensitivity relative to the vehicle treatment and both monotherapy control groups (Extended Data Fig

Current evidence suggests these are long-term treatments, similar to blood pressure or cholesterol medications

Therefore, the initiation of therapy with GLP-1RAs contributes to significant weight loss

One 2025 study projected more than $18 billion in healthcare savings over a decade

The SURPASS program, a series of phase III clinical trials, was conducted to assess the therapeutic efficacy (glycemic control and body weight reduction), safety, and tolerability of tirzepatide in people with T2D

The net effect of the mismatch between increased ATP demand and decreased ATP generation is increased renal oxygen consumption, ultimately rendering the kidney susceptible to renal hypoxia [15]